Novavax, Inc. revenue breakdown overview

Novavax, Inc. revenue for the last year amounted to 983.71 M USD, the most of which — 983.71 M USD — came from its highest performing source at the moment, Innovative Vaccines, the year earlier bringing 1.98 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought Novavax, Inc. 983.71 M USD, and the year before that — 1.98 B USD.